ACCS is delivering state-of-the-art medical support far forward that is not only safe and effective, but extremely small, lightweight and rugged. The ACCS “system of systems” provides the capability to deploy in one compact system.
ACCS can be deployed in CASEVAC, aboard ships or on land-based medical facilities and is designed for medical surge capabilities, deploys in decision assist mode or fully autonomous modes including closed loop control (CLC).
D/S allows care providers to delegate non-essential therapy control to ACCS or implement into a multi-casualty care mode. The goal of ACCS is to effectively and efficiently link the patient to the care provider without losing data from the point of injury through to disposition.
Future Naval Capabilities (FNC): Force Health Protection Program Reviews
July 10 – 14, 2017 – Arlington, VA, Holiday Inn
This meeting will consist of several days of performer presentations, demonstrations and breakout sessions. The presentations are meant to discuss the current and near future work that is being conducted by the ONR research team. Final time schedule TBD.
ONR 2017 Naval Future Force Science and Technology (S&T) EXPO
July 20-21, 2017 – Walter E. Washington Convention Center, Washington, D.C
MHSRS: Military Health System Research Symposium
August 27-30, 2017 – Gaylord Palms Resort & Convention Center, Kissimmee, Florida
The Department of Defense (DOD) hosts MHSRS annually to discuss “military-unique research and development,” focusing on military medicine. This year, MHSRS will feature 60 abstract-driven breakout sessions, including breakout sessions on infectious disease, traumatic brain injury, psychological health, military global health engagement, and injury prevention, as well as precision medicine and women’s health. One of the big themes is Prolonged Field Care or PFC. We will focus on this aspect of the ACCS as part of the demo’s.
The Hypoxia Alert and Mitigation System (HAMS) is now in Phase 2. The HAMS II is a full system development of a missionized and robust platform for detection/prediction/ anticipation of hypoxia based on a novel wearable sensing suite incorporating warning and state assessment and will eventually include modes of mitigation. HAMS will enter operational use by both ground troops and CASEVAC. The team of Athena GTX®, Inc. and Criterion Analysis Inc. (CAI), while in cooperation with other HAMS subcontractors to the ONR, is the prime integrator and developer of the product.
The goal of HAMS is to provide optimal protection of military personnel via high speed miniaturized intelligent monitoring and adaptive modeling. HAMS accounts for individual differences in physiologic tolerance and provides a timely warning such that personnel can take corrective action before missions are compromised or injuries aggravated. HAMS will address cognitive and physiological workload at altitude, and the dynamic impact of sustained high altitude operations. Hams operational use will include transitioning to a medical monitoring platform if and when needed. The effort under this program allows for iterative and progressive prototype development with user testing to occur leading to options for development of systems that are FDA cleared and ready for field use.